The role of cyclooxygenase-2/prostanoid pathway in visceral pain induced liver stress response in rats

Chinese Medical Journal

Volumn 120, Issue 20, 2007, Pages 1813-1819

  Piston, Donald ^a   Wang, Shan ^a   Feng, Yi ^a   Ye, Ying Jiang ^a   Zhou, Jing ^a   Jiang, Ke Wei ^a   Xu, Feng ^a   Zhao, Yong ^a   Cui, Zhi Rong ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

Cyclooxygenase 2; Liver injury; Prostanoid; Stress; Visceral pain

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; ACETIC ACID; CYCLOOXYGENASE 2; GLUTATHIONE TRANSFERASE; MESSENGER RNA; MORPHINE; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PROSTAGLANDIN E2; PROSTANOID; THROMBOXANE B2;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; HISTOPATHOLOGY; LIVER INJURY; LIVER LEVEL; MALE; NONHUMAN; PAIN ASSESSMENT; RAT; SPRAGUE DAWLEY RAT; STRESS; VISCERAL PAIN;

EID: 36148939830     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200710020-00017     Document Type: Article

References (25)

1. Chandrasekharan NV, Dai H, Roos KL, Evanson NK, Tomisk J, Elton TS, et al. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proc Natl Acad Sci USA 2002; 99: 13926-13931.
2. Fermor B, Weinberg JB, Pisetsky DS, Misukonis MA, Fink C, Guilak F. Induction of cyclooxygenase-2 by mechanical stress through a nitric oxide-regulated pathway. Osteoarthritis Cartilage 2002; 10: 792-798.
3. Miettinen S, Fusco FR, Yrjänheikki J, Keinänen R, Hirvonen T, Roivainen R, et al. Spreading depression and focal brain ischemia induce cyclooxygenase-2 in cortical neurons through, N-methyl-D-aspartic acid-receptors and phospholipase A2. Proc Natl Acad Sci USA 1997; 94: 6500-6505.
4. Nanji AA, Miao L, Thomas P, Rahemtulla A, Khwaja S, Zhao S, et al. Enhanced cyclooxygenase-2 gene expression in alcoholic liver disease in the rat. Gastroenterology 1997; 112: 943-951.
5. Failli P, DeFRANCO RM, Caligiuri A, Gentilini A, Romanelli RG, Marra F, et al. Nitrovasodilators inhibit platelet-derived growth factor-induced proliferation and migration of activated human hepatic, stellate cells. Gastroenterology 2000; 119: 479-492
6. Waris G, Siddiqui A. Hepatitis- C virus stimulates the expression of cyclooxygenase-2 via oxidative stress: role of prostaglandin E2 in RNA replication: J Virol 2005; 79: 9725-9734.
7. Besse T, Gustin T, Claeys N, Schroeyers P, Lambotte L. Effect of PGI2 and thromboxane antagonist on liver ischemic injury. Eur Surg Res 1989; 21: 213-217.
8. Isozaki H, Okajima K, Hara H, Kobayashi M, The-protective effect of thromboxane A2 synthetase inhibitor against ischemic liver injury. Surg Today 1994; 24: 435-440.
9. Kim SH, Lee SM. Expression of hepatic vascular stress genes following ischemia/reperfusion and subsequent endotoxemia. Arch Pharm Res 2004; 27: 769-775.
10. Kuzumoto Y, Sho M, Ikeda N, Hamada K, Mizuno T, Akashi S, et al. Significance and therapeutic potential of prostaglandin E2, receptor in hepatic ischemia/reperfusion injury in mice. Hepatology 2005; 42: 608-617.
11. Jakoby WB. The glutathione S-transferases: a group of multifunctional detoxification proteins. Adv Enzymol Relat Areas Mol Biol 1978; 46: 383-414.
12. Zhang Z, Sun M, Wang H, Le J. Protective effect of erigeron injections on hepatotoxicity induced by intestinal ischemia-reperfusion in mice. J Hyg Res (Chin) 2001; 30: 86-88.
13. Sreepriya M, Devaki T, Balakrishna K, Apparanantham T. Effect of Indigofera tinctoria Linn on liver antioxidant defense system during D-galactosamine/endotoxin-induced acute hepatitis in rodents. Indian J Exp Biol 2001; 39: 181-184.
14. Jajte J, Stetkiewicz J, Wronska-Nofer T. Combined exposure to m-xylene and ethanol: oxidative stress in the rat liver. Int J Occup Med Environ Health 2003; 16: 345-350.
15. Williams CS, Mann M, DuBois RN. The role of cyclooxygenases in inflammation, cancer, and development. Oncogene 1999; 18: 7908-7916.
16. Buttar NS, Wang KK. The "aspirin" of the new millennium: cyclooxygenase-2 inhibitors. Mayo Clin Proc 2000; 75: 1027-1038.
17. Fosslien E. Biochemistry of cyclooxygenase (COX)-2 inhibitors and molecular pathology of COX-2 in neoplasia. Crit Rev Clin Lab Sci 2000; 37: 431-502.
18. Tilley SL, Coffman TM, Koller BH. Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes. J Clin Invest 2001; 108: 15-23.
19. Hui AY, Cheng AS, Chan HL, Go MY, Chan FK, Sakata R, et al. Effect of prostaglandin E2 and prostaglandin I2 on PDGF-induced proliferation of L190, a human hepatic stellate cell line. Prostaglandins Leukot Essent Fatty Acids 2004; 71: 329-333.
20. Tsugawa K, Hashizume M, Migou S, Kishihara F, Kawanaka H, Tomikawa M, et al. A selective cyclooxygenase-2 inhibitor, NS-398, may improve portal hypertension without inducing gastric mucosal injury. J Gastroenterol Hepatol 1999; 14: 642-651.
21. Bae SH, Jung ES, Park YM, Kim BS, Kim BK, Kim DG, et al. Expression of cyclooxygenase-2 (COX-2) in hepatocellular carcinoma and growth inhibition of hepatoma cell lines by a COX-2 inhibitor, NS-398. Clin Cancer Res 2001; 7: 1410-1418.
22. Nanji AA, Khwaja S, Rahemtulla A, Miao L, Zhao S, Tahan SR. Thromboxane inhibitors attenuate pathological changes in alcoholic liver disease in the rat. Gastroenterology 1997; 112: 200-207.
23. Chung C, Gottstein J, Blei AT. Indomethacin prevents the development of experimental ammonia-induced brain edema in rats after portacaval anastomosis. Hepatology 2001; 34: 249-254.
24. Suliburk JW, Helmer KS, Gonzalez EA, Robinson EK, Mercer DW. Ketamine attenuates liver injury attributed to endotoxemia: role of cyclooxygenase-2. Surgery 2005; 138: 134-140.
25. Zhang F, Warskulat U, Wettstein M, Schreiber R, Henninger HP, Decker K, et al. Hyperosmolarity stimulates prostaglandin synthesis and cyclooxygenase-2 expression in activated rat liver macrophages. Biochem J 1995; 312: 135-143.